MedTrace Logo

Evaluation of D-chiro-inositol Treatments

NCT05448378 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2022-09-19

No results posted yet for this study

Summary

Healthy women will take tablets containing 600 mg D-chiro-inositol twice per day for one month. We will evaluate metabolic and hormonal.parameters, as insulienmia, glycemia, estradiol, testosterone.

Conditions

  • Inositol
  • Testosterone
  • Insulin
  • Ovulation
  • Asprosin

Interventions

DIETARY_SUPPLEMENT

D-chiro-inositol

D-chiro-inositol 600 mg twice per day on an empty stomach for one month

Sponsors & Collaborators

  • Lo.Li.Pharma s.r.l

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-04
Primary Completion
2022-08-30
Completion
2022-09-16

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05448378 on ClinicalTrials.gov